Copied
 
 
Formål
Formål
Virksomhedens formål er at investere i selskaber, som hovedsageligt beskæftiger sig med udvikling og salg af lægemidler.
Sidst opdateret den 18.12.2019 og angivet som gældende fra 30.05.2014 (3622 dage).
Ingen historik.
Status
Virksomhedsstatus
NORMAL.
Sidst opdateret den 18.12.2019 og angivet som gældende fra 04.09.2008 (5716 dage).
Ingen historik.
Branche
Branche
Investeringsselskaber (643030).
Sidst opdateret den 27.11.2019 og angivet som gældende fra 01.01.2018 (2310 dage).
HistorikStartStop
Investeringsselskaber (643030)01.01.2018
Investeringsselskaber (643030)04.09.200831.12.2017
Revision
Revisionfravalgt
false.
Sidst opdateret den 18.12.2019 og angivet som gældende fra 04.09.2008 (5716 dage).
Ingen historik.
Revisor
Revisor
DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB
Sidst opdateret den 27.09.2019 og angivet som gældende fra 06.03.2017 (2611 dage).
HistorikStartStop
DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB06.03.2017
EY Godkendt Revisionspartnerselskab10.10.201406.03.2017
ERNST & YOUNG DENMARK P/S12.07.201210.10.2014
EY Danmark A/S04.09.200812.07.2012
Form
Virksomhedsform
40.
Sidst opdateret den 18.12.2019 og angivet som gældende fra 04.09.2008 (5716 dage).
Ingen historik.
Kontakt
Ingen nuværende registrering.
Ingen historik.
Telefon
Ingen nuværende registrering.
Ingen historik.
Navne
Ingen historik.
Tegningsregel
Tegningsregel
Virksomheden tegnes af komplementaren.
Sidst opdateret den 18.12.2019 og angivet som gældende fra 30.05.2014 (3622 dage).
Fortolkning (1 tegningsmulighed)
komplementaren
Ingen historik.
Ansatte
29.04.2024
Ingen historik.
Kapital
29.04.2024
Ingen historik.
Fra årsrapport
Type af revisorbistand:Revisionspåtegning
Navn på revisionsvirksomhed:Deloitte Statsautoriseret Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:33963556
Beskrivelse af revisor:Statsautoriseret revisor
Virksomhedens regnskabsklasse:Regnskabsklasse C, mellemstor virksomhed
Grundlag for konklusion (revision):Basis for opinionWe conducted our audit in accordance with International Standards on Auditing (ISAs) and additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the "Auditor's responsibilities for the audit of the financial statements" section of this auditor's report. We are independent of the Entity in accordance with the International Ethics Standards Board for Accountants' International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):OpinionWe have audited the financial statements of NB Public Equity K/S for the financial year 1 January – 31 December 2022, which comprise Income statement, balance sheet, statement of changes in equity,and notes, including the summary of significant accounting policies. The financial statements are preparedin accordance with the Danish Financial Statements Act. In our opinion, the financial statements give a true and fair view of the entity's financial position at31 December 2022 and of its financial performance for the financial year 1 January - 31 December 2022in accordance with the Danish Financial Statement Act.
Udtalelse om ledelsesberetningen (revision):Statement on the Management's commentaryThe General Partner is responsible for the management commentary. Our opinion on the financial statements døs not cover the management commentary, and we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the management commentary and, in doing so, consider whether the management commentary is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether the management commentary provides the information required under the Danish Financial Statements Act. Based on the work we have performed, we conclude that the management commentary is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement of the management commentary.
Bibranche
Ingen nuværende registrering.
Ingen historik.
Børsnoteret
29.04.2024
Ingen nuværende registrering.
Ingen historik.
Hjemmeside
29.04.2024
Ingen nuværende registrering.
Ingen historik.